Why are bacteria resistant to antibiotics? Did you know? 26 billion – the annual cost of antibiotic-resistant infections to US healthcare(1) Antibiotics still not used properly Antibiotics are drugs that fight an infection caused by bacteria by preventing it from … Read More
THE INVISIBLE SHIELDS
VERSATILE, PERSONALISED COATINGS
FOR MEDICAL DEVICES
FOR DAILY USE*
*Shown to inactivate SARS-CoV-2 (Covid-19)
Multifunctional coatings specially formulated to prevent infection and bacterial resistance.
of cases related with medical devices
Diabetic foot ulcers
Antibiotic resistant bacteria
deaths in Europe each year
deaths expected worldwide by 2050
ROBOTS / TESTS / CO-DEVELOPMENT
SPARTHA Medical is a spin-off from INSERM UMR1121 a public research institute with more than 20 years of experience in development of coating.
SPARTHA Medical’s core technologies are patented-based inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION
OUR PAGE ON THE CENTRE DE RECHERCHE DE BIOMEDECINE DE STRASBOURG
Who are we? SPARTHA technology develops coatings based on natural biopolymers with antimicrobial, antiviral, and anti-inflammatory properties. Our main ambition is to protect medical devices and all types of surfaces from infectious risks by offering easy-to-apply and multifunctional coating solutions. … Read More
The EIC Accelerator is the European Innovation Council’s (EIC) programme for SMEs. Launched by the European Commission in September 2019 in its pilot phase ahead of Horizon Europe. The EIC aims to stimulate Europe’s economic growth by enabling visionary and … Read More
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Directorate-General for Communications Networks, Content and Technology. Neither the European Union nor the granting authority can be held responsible for them.